{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-001399","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2024-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.961280+00:00","generated_at":"2026-06-05T00:26:13.797485+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Sonoma Pharmaceuticals increases ATM offering capacity by $785,679","bullets":["Amendment No. 1 to Dec 2023 Equity Distribution Agreement with Maxim Group LLC allows sale of up to $785,679 in additional common shares.","Shares will be sold under existing effective S-3 registration statement (File No. 333-275311) and a prospectus supplement filed March 8, 2024.","No specific use of proceeds disclosed; prior ATM offerings typically used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-001399","json":"https://secwatch.observer/filing/0001683168-24-001399.json","markdown":"https://secwatch.observer/filing/0001683168-24-001399.md","text":"https://secwatch.observer/filing/0001683168-24-001399.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824001399/0001683168-24-001399-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824001399/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T00:26:13.797485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dd46c76263bf6f8a9b03140090ca085d65c0e905","claim":"Sonoma Pharmaceuticals, Inc. amended Amendment No. 1 with Maxim Group LLC valued at up to $785,679 (effective 2024-03-08).","evidence_excerpt":"On March 8, 2024, the Company entered into an amendment to the Agreement (“Amendment No. 1”) to provide for the sale of up to $785,679 of additional shares under the Agreement.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824001399/0001683168-24-001399-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Maxim Group LLC"},{"label":"Value","value":"up to $785,679"},{"label":"Effective","value":"2024-03-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}